Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2,527,521,347
-
Number of holders
-
2,532
-
Total 13F shares, excl. options
-
1,875,444,213
-
Shares change
-
-12,157,426
-
Total reported value, excl. options
-
$155,469,945,637
-
Value change
-
-$969,657,574
-
Put/Call ratio
-
76%
-
Number of buys
-
1,250
-
Number of sells
-
-1,015
-
Price
-
$82.95
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q3 2020
2,683 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q3 2020.
Merck & Co., Inc. - Common Stock (MRK) has 2,532 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,875,444,213 shares
of 2,527,521,347 outstanding shares and own 74% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (209,865,924 shares), BlackRock Inc. (196,888,895 shares), STATE STREET CORP (117,030,114 shares), WELLINGTON MANAGEMENT GROUP LLP (44,729,366 shares), BANK OF AMERICA CORP /DE/ (44,038,776 shares), GEODE CAPITAL MANAGEMENT, LLC (41,363,672 shares), Capital International Investors (38,213,851 shares), NORTHERN TRUST CORP (33,740,381 shares), Bank of New York Mellon Corp (32,826,443 shares), and JPMORGAN CHASE & CO (28,445,148 shares).
This table shows the top 2,532 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.